Pelagos Insurance director Charles Mathias to resign
Pelagos Insurance Capital Limited reports that director Charles Mathias has notified the Board of his intention to resign as a director and as a member of the Board’s Risk Committee and Investment Committee, effective August 2, 2026.
Rhea-AI Filing Summary
Pelagos Insurance Capital Limited reports that director Charles Mathias has notified the Board of his intention to resign as a director and as a member of the Board’s Risk Committee and Investment Committee, effective August 2, 2026.
Mathias was nominated by TFP Intermediate Holdings II Limited, known as The Fidelis Partnership, under its nomination right in Bye-Law 54.3(a)(iv). Under Bye-Law 54.3(c), The Fidelis Partnership is entitled to designate a successor to serve the remainder of his term. The report is incorporated by reference into Pelagos Insurance’s existing Form S-8 and Form F-3 registration statements in the United States.
Positive
- None.
Negative
- None.
Key Figures
Director resignation effective date: August 2, 2026
Resignation notice date: July 9, 2026
Form S-8 file number: 333-273105
+1 more
4 metrics
Director resignation effective date
August 2, 2026
Effective date of Charles Mathias’ resignation from the Board and its committees
Resignation notice date
July 9, 2026
Date on which Charles Mathias announced his intention to resign
Form S-8 file number
333-273105
U.S. Form S-8 registration statement into which this report is incorporated
Form F-3 file number
333-287332
U.S. Form F-3 registration statement into which this report is incorporated
Key Terms
foreign private issuer, Form 6-K, Form S-8, Form F-3, +2 more
6 terms
foreign private issuer regulatory
"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
Form 6-K regulatory
"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER"
A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.
Form S-8 regulatory
"registration statements on Form S-8 (File No. 333-273105)"
A Form S-8 is a U.S. Securities and Exchange Commission registration that lets a public company set aside shares for employee benefit plans and stock-based compensation. Think of it as opening a dedicated account that authorizes the company to issue or reserve stock for workers and directors; it matters to investors because it enables share dilution when those awards are granted or exercised and signals how management is compensated and incentivized.
Form F-3 regulatory
"registration statements on Form F-3 (File No. 333-287332)"
Form F-3 is a U.S. securities filing that lets eligible foreign companies pre-register and then quickly sell shares or other securities to raise money, because they already meet ongoing reporting and size tests. For investors it signals that the company is up-to-date with regulatory disclosure and has an efficient way to issue new securities — similar to a pre-approved credit line — which can mean faster capital raises but also potential dilution of existing holdings.
Bye-Law 54.3(a)(iv) regulatory
"pursuant to its right under Bye-Law 54.3(a)(iv) of the Amended"
Risk Committee other
"resign as a member of the Board’s Risk Committee and Investment"
A risk committee is a group, usually part of a company’s board or senior leadership, tasked with spotting, assessing and guiding how the company manages threats to its finances, operations and compliance—think of it as a regular safety inspection for the business. Investors care because the committee’s work influences how likely the company is to avoid big losses, regulatory trouble or surprises that can hurt earnings and share value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What board change did Pelagos Insurance Capital (PLGO) disclose?
Pelagos Insurance Capital disclosed that director Charles Mathias will resign from the Board and its Risk and Investment Committees effective August 2, 2026, creating a vacancy for a successor designated by The Fidelis Partnership.
When is Charles Mathias’s resignation from PLGO’s board effective?
The resignation of Charles Mathias from Pelagos Insurance Capital’s Board is effective on August 2, 2026. He communicated his intention to resign on July 9, 2026, covering both his board seat and committee memberships.
Who nominated Charles Mathias to the PLGO board?
Charles Mathias was nominated to Pelagos Insurance Capital’s Board by TFP Intermediate Holdings II Limited, also called The Fidelis Partnership, under its nomination right in Bye-Law 54.3(a)(iv) of the company’s Amended and Restated Bye-Laws.
Who can select the successor to Charles Mathias on PLGO’s board?
Under Bye-Law 54.3(c), The Fidelis Partnership is entitled to designate a successor to Charles Mathias to serve the remainder of his board term at Pelagos Insurance Capital following his effective resignation.
How does this PLGO 6-K affect existing U.S. registration statements?
The report is incorporated by reference into Pelagos Insurance Capital’s U.S. registration statements on Form S-8 (File No. 333-273105) and Form F-3 (File No. 333-287332), making the disclosed board change part of those offering documents.
Does PLGO’s filing mention any financial or operational impact from the resignation?
The filing describes a governance change only, namely the resignation of Charles Mathias and The Fidelis Partnership’s right to designate a successor. It does not provide additional detail on financial or operational consequences.
AI-generated analysis. How Rhea-AI works. Not financial advice.
